MLi-2
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-100411-5MG | 5 mg | 241,00 | Add | |
| HY-100411-1ML | 10mM/1mL | 265,00 | Add | |
| HY-100411-10MG | 10 mg | 364,00 | Add | |
| HY-100411-50MG | 50 mg | 1'255,00 | Add | |
| HY-100411-100MG | 100 mg | 2'016,00 | Add | |
| HY-100411-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Autophagy |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.8% |
| Molecular Formula | C21H25N5O2 |
| Molecular Weight | 379.46 |
| CAS-Number | 1627091-47-7 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
